Arvind Kush

Chief Financial Officer, RayzeBio, Inc.

Companies

Inhibikase Therapeutics, Inc.Board member Oct 23, 2024 to now¹
RayzeBio, Inc.Chief financial officer Sep 14, 2023 to Feb 27, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Inhibikase Therapeutics, Inc. IKT145,000 shares³$265.4K at $1.83Oct 21, 2024
RayzeBio, Inc.0 shares⁴Feb 26, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 21, 2024Bought 145,000 shares at $1.37 of Inhibikase Therapeutics, Inc.³
Feb 26, 2024Returned to company 78,433 shares at $62.50 of RayzeBio, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARInhibikase Therapeutics, Inc., Board member
2
SEC EDGARRayzeBio, Inc., Chief financial officer
3
SEC EDGARInhibikase Therapeutics, Inc. shares after the filing of Oct 21, 2024
4
SEC EDGARRayzeBio, Inc. shares after the filing of Feb 26, 2024